(Q38240527)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25130042%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

Genetic manipulation and genetic variation of the kallikrein-kinin system: impact on cardiovascular and renal diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25130042%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

Jean-Pierre Girolami

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25130042%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Nelly Blaes

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25130042%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Nadine Bouby

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25130042%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

François Alhenc-Gelas

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25130042%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

1 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25130042%20AND%20SRC:MED&resulttype=core&format=json

Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques

12 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25130042%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25130042%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

145-196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25130042%20AND%20SRC:MED&resulttype=core&format=json

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

12 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Altered cardiac bradykinin metabolism in experimental diabetes caused by the variations of angiotensin-converting enzyme and other peptidases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Kinin release from normally perfused and ischaemic isolated rat hearts: effect of strain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Salt-sensitive hypertension in bradykinin B2 receptor knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Stimulation of prostaglandin formation by vasoactive mediators in cultured human endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Kinins as therapeutic agents in cardiovascular and renal diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Vascular reactivity and ACE activity response to exercise training are modulated by the +9/-9 bradykinin B₂ receptor gene functional polymorphism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Clinical impact of an angiotensin I-converting enzyme insertion/deletion and kinin B2 receptor +9/-9 polymorphisms in the prognosis of renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The genetic factor in acute myocardial infarction with hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The effects of polymorphisms in genes from the renin–angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels are dependent on environmental context

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Genetic and dietary control of plasma tissue kallikrein secretion and urinary kinins exretion in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Altered frequency of a promoter polymorphic allele of the kinin B1 receptor gene in inflammatory bowel disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Altered glucose homeostasis and hepatic function in obese mice deficient for both kinin receptor genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin inhibits hepatic gluconeogenesis in obese mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Potential genetic risk factors in angiotensin-converting enzyme-inhibitor-induced angio-oedema

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Ramiprilat increases bradykinin outflow from isolated hearts of rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Effects of bradykinin in the rat isolated perfused heart: role of kinin receptors and endothelium-derived relaxing factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin augments insulin-stimulated glucose transport in rat adipocytes via endothelial nitric oxide synthase-mediated inhibition of Jun NH2-terminal kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Cardiovascular risk associated with interactions among polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Effects of Antihypertensive Treatment on Insulin Sensitivity With Special Reference to ACE Inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Renal angiotensin-converting enzyme and blood pressure control

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

A gene for high urinary kallikrein may protect against hypertension in Utah kindreds

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Association and interaction of -58C>T and ±9 bp polymorphisms of BDKRB2 gene causing susceptibility to essential hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Hereditary angioedema: a bradykinin-mediated swelling disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin inhibits high glucose- and growth factor-induced collagen synthesis in mesangial cells through the B2-kinin receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Targeting the 'Janus face' of the B2-bradykinin receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Partial human genetic deficiency in tissue kallikrein activity and renal calcium handling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Kallikrein protects against microalbuminuria in experimental type I diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Effect of ramipril on the incidence of diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Identification of polymorphic sites of the human bradykinin B2 receptor gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Polymorphisms in the gene for the human B2-bradykinin receptor. New tools in assessing a genetic risk for bradykinin-associated diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

High salt-induced hypertension in B2 knockout mice is corrected by the ETA antagonist, A127722

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin B2BKR receptor polymorphism and left-ventricular growth response

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Increased tissue kallikrein levels in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Structure and expression of two kininogen genes in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Effect of captopril, losartan, and bradykinin on early steps of insulin action

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Antidiabetic efficacy of bradykinin antagonist R-954 on glucose tolerance test in diabetic type 1 mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Angiotensin II-induced hypertension in bradykinin B2 receptor knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Protective effects of bradykinin on the ischaemic heart: implication of the B1 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Role of tissue kallikrein in regulation of tubule function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Novel kinin B1 receptor agonists with improved pharmacological profiles

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Sequence variation of bradykinin receptors B1 and B2 and association with hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Genetics of angiotensin I-converting enzyme

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Congenital deficiency in plasma kallikrein and kininogens in the brown Norway rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Effect of kinin B2 receptor ablation on skeletal muscle development and myostatin gene expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Kinin B1 receptor enhances the oxidative stress in a rat model of insulin resistance: outcome in hypertension, allodynia and metabolic complications

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Blockade of kinin B(1) receptor reverses plasma fatty acids composition changes and body and tissue fat gain in a rat model of insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Potential role of bradykinin in forearm muscle metabolism in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I--converting enzyme gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Tissue kallikrein permits early renal adaptation to potassium load

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Enhanced blood pressure sensitivity to deoxycorticosterone in mice with disruption of bradykinin B2 receptor gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Rescue of impaired angiogenesis in spontaneously hypertensive rats by intramuscular human tissue kallikrein gene transfer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Targeting kinin B(1) receptor for therapeutic neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in type 1 diabetic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Akt/protein kinase B and endothelial nitric oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Is there an interaction between BDKRB2−9/+9 and GNB3 C825T polymorphisms and elite athletic performance?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin B2 receptor gene C-58T polymorphism and insulin resistance. A study on obese patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Susceptibility to metanephric apoptosis in bradykinin B2 receptor null mice via the p53-Bax pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Role of plasma kallikrein in diabetes and metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Lack of association of a 9 bp insertion/deletion polymorphism within the bradykinin 2 receptor gene with myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Exon 1 polymorphism of the B2BKR gene does not influence the clinical status of patients with hereditary angioedema

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Insertion/deletion polymorphism of the bradykinin type 2 receptor gene influence diastolic blood pressure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Relationship of Bradykinin B2 Receptor Gene Polymorphism with Essential Hypertension and Left Ventricular Hypertrophy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Expression of TEX101, regulated by ACE, is essential for the production of fertile mouse spermatozoa

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Angiotensin I-Converting Enzyme Gene Polymorphism Is Associated With Myocardial Infarction, but Not With Retinopathy or Nephropathy, in NIDDM

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-Americans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Tissue kallikrein stimulates Ca(2+) reabsorption via PKC-dependent plasma membrane accumulation of TRPV5.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Renal kallikrein excretion as a distal nephrotoxicity marker during cadmium exposure in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Inverse relationship between renal and urinary kallikrein during chromate-induced acute renal failure in rat: urinary kallikrein excretion as a possible recovery index

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The absence of intrarenal ACE protects against hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Tissue kallikrein deficiency and renovascular hypertension in the mouse.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Role of endogenous bradykinin in human coronary vasomotor control

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The role of the kallikrein-kinin system genes in the salt sensitivity of blood pressure: the GenSalt Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The expression of angiotensin-I converting enzyme in human atherosclerotic plaques is not related to the deletion/insertion polymorphism but to the risk of restenosis after coronary interventions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Changes in components of kinin system and hemodynamics in acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin B2 type receptor activation regulates fluid and electrolyte transport in the rabbit kidney.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Arteriogenesis is modulated by bradykinin receptor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Stimulation of cyclic GMP production via AT2 and B2 receptors in the pressure-overloaded aorta after banding

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Urinary kallikrein excretion in essential and mineralocorticoid hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

+9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Effects of Dietary Potassium and Race on Urinary Excretion of Kallikrein and Aldosterone in Man

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Kinin, a mediator of diabetes-induced glomerular hyperfiltration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Association of the human bradykinin B2 receptor gene with chronic renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The kallikrein-kinin system in health and in diseases of the kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The human bradykinin B2 receptor gene: full length cDNA, genomic organization and identification of the regulatory region

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The renal kallikrein-kinin system: its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The kallikrein-kinin system and oxidative stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

G(-699)/C polymorphism in the bradykinin-1 receptor gene in patients with renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Male–female differences in fertility and blood pressure in ACE-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Local kallikrein-kinin system is involved in podocyte apoptosis under diabetic conditions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Detrimental implication of B1 receptors in myocardial ischemia: evidence from pharmacological blockade and gene knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Tissue kallikrein preventing the restenosis after stenting of symptomatic MCA atherosclerotic stenosis (KPRASS).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The high-molecular-mass kininogen deficient rat expresses all kininogen mRNA species, but does not export the high-molecular-mass kininogen synthesized

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin β2 receptor -58T/C gene polymorphism and essential hypertension: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin type-2 receptor expression correlates with age and is subjected to transcriptional regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

A comparison of the effects of locally and systemically administered kinins on coronary blood flow and myocardial metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Renovascular hypertension in bradykinin B2-receptor knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Role of the bradykinin B2 receptor in the maturation of blood pressure phenotype: lesson from transgenic and knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Local methacholine but not bradykinin potentiates insulin-mediated glucose uptake in muscle in vivo by augmenting capillary recruitment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Kallikrein along the rabbit microdissected nephron: a micromethod for its measurement. Effect of adrenalectomy and DOCA treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Exacerbation of DSS-induced colitis in mice lacking kinin B(1) receptors through compensatory up-regulation of kinin B(2) receptors: the role of tight junctions and intestinal homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Tissue kallikreins and kinins: regulation and roles in hypertensive and diabetic diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Cardioprotective effects of a selective B(2) receptor agonist of bradykinin post-acute myocardial infarct

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough: the role of ACE, ABO, and BDKRB2 genes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Expression cloning of a rat B2 bradykinin receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Increased susceptibility to endotoxic shock in transgenic rats with endothelial overexpression of kinin B(1) receptors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Angiotensin-converting enzyme in non-neoplastic kidney diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Heterogeneous distribution of angiotensin I-converting enzyme (CD143) in the human and rat vascular systems: vessel, organ and species specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin B2 receptor gene (-58T/C) polymorphism influences baroreflex sensitivity in never-treated hypertensive patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Urinary kallikrein activity in the hypertension of renal parenchymal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Association of B2 receptor polymorphisms and ACE activity with ACE inhibitor-induced angioedema in black and mixed-race South Africans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Interactions of genetic variants with physical activity are associated with blood pressure in Chinese: the GenSalt study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Partial genetic deficiency in tissue kallikrein impairs adaptation to high potassium intake in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Kinin B1 receptor in adipocytes regulates glucose tolerance and predisposition to obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Promoter polymorphism of the beta2 bradykinin receptor gene is associated with essential hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin B(2) receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Association of polymorphisms of the renin-angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Angiotensin II induces angiogenesis in the hypoxic adult mouse heart in vitro through an AT2-B2 receptor pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism, angiographically defined coronary artery disease and myocardial infarction in patients with type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The linkage and association of the gene encoding upstream stimulatory factor 1 with type 2 diabetes and metabolic syndrome in the Chinese population

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Angiotensin-converting enzyme and bradykinin gene polymorphisms and cough: A meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

A meta-analysis of the bradykinin B2 receptor gene --58C/T polymorphism with hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

A local kallikrein-kinin system is present in rat hearts

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

SNPs in MicroRNA Binding Sites in 3′-UTRs of RAAS Genes Influence Arterial Blood Pressure and Risk of Myocardial Infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Plasma bradykinin in angio-oedema.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Evidence for a role of the plasma kallikrein-kinin system in acute inflammation: reduced exudation during carrageenin- and kaolin-pleurisies in kininogen-deficient rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Immunolocalization of renal kallikrein-like substance in rat urinary bladder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Meta-analysis of genome-wide association studies for panic disorder in the Japanese population

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Cardiac interstitial bradykinin release during ischemia is enhanced by ischemic preconditioning

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Kallikrein gene 'knock-down' by small interfering RNA transfection induces a profibrotic phenotype in rat mesangial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Sensory and signaling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Tissue kallikrein-deficient mice display a defect in renal tubular calcium absorption

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Defective ENaC processing and function in tissue kallikrein-deficient mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Tissue kallikrein deficiency aggravates cardiac remodelling and decreases survival after myocardial infarction in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin type 2 receptor -9/-9 genotype is associated with triceps brachii muscle hypertrophy following strength training in young healthy men

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Selective kinin receptor agonists as cardioprotective agents in myocardial ischemia and diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Tissue kallikrein deficiency, insulin resistance, and diabetes in mouse and man.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Insulin-induced glucose transporter (GLUT1 and GLUT4) translocation in cardiac muscle tissue is mimicked by bradykinin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Evidence that kinin B2 receptor expression is upregulated by endothelial overexpression of B1 receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

SNP-by-fitness and SNP-by-BMI interactions from seven candidate genes and incident hypertension after 20 years of follow-up: the CARDIA Fitness Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The bradykinin beta 2 receptor (BDKRB2) and endothelial nitric oxide synthase 3 (NOS3) genes and endurance performance during Ironman Triathlons

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Further pharmacological evaluation of a novel synthetic peptide bradykinin B2 receptor agonist

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

In vivo bradykinin B2 receptor activation reduces renal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Decreased renal NO excretion and reduced glomerular tuft area in mice lacking the bradykinin B2 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Hemodynamic and renal involvement of B1 and B2 kinin receptors during the acute phase of endotoxin shock in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Association of genome variations in the renin-angiotensin system with physical performance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

A second expressed kininogen gene in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Genetic variation in angiotensin-converting enzyme-related pathways associated with sudden cardiac arrest risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardium

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

AT2 receptor agonists: hypertension and beyond

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Vasodilator actions of acetylcholine, A23187 and bradykinin in the guinea-pig isolated perfused heart are independent of prostacyclin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Human metabolic individuality in biomedical and pharmaceutical research

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Emerging role of microglial kinin B1 receptor in diabetic pain neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Additive renoprotective effects of B2-kinin receptor blocker and PPAR-γ agonist in uninephrectomized db/db mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Study of candidate genes affecting the progression of renal disease in autosomal dominant polycystic kidney disease type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The kallikrein-kinin system in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Myocardial expression of rat bradykinin receptors and two tissue kallikrein genes in experimental diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Myocardial bradykinin B2-receptor expression at different time points after induction of myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Development of diabetic cardiomyopathy and the kallikrein-kinin system--new insights from B1 and B2 receptor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Associations of polymorphisms of eight muscle- or metabolism-related genes with performance in Mount Olympus marathon runners.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Myocardial protection with enalaprilat in patients unresponsive to ischemic preconditioning during percutaneous coronary intervention

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The Kallikrein-Kinin System in Bartter's Syndrome and Its Response to Prostaglandin Synthetase Inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Antihypertensive role of tissue kallikrein in hyperaldosteronism in the mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Pathophysiology of genetic deficiency in tissue kallikrein activity in mouse and man

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Human tissue kallikrein induces hypotension in transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Hypotension in transgenic mice overexpressing human bradykinin B2 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Enhanced renal function in bradykinin B(2) receptor transgenic mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Genetic variation in the promoter region of the beta2 bradykinin receptor gene is associated with essential hypertension in a Chinese Han population

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Doxorubicin cardiomyopathy-induced inflammation and apoptosis are attenuated by gene deletion of the kinin B1 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin receptor gene variant and human physical performance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Lack of association between ACE and bradykinin B2 receptor gene polymorphisms and ACE inhibitor-induced coughing in hypertensive Koreans

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Genetic influence on baroreflex sensitivity in normotensive young men

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

The kinin B1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Protective role of AT(2) and B(1) receptors in kinin B(2)-receptor-knockout mice with myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Targeted disruption of the bradykinin B(2) receptor gene in mice alters the ontogeny of the renin-angiotensin system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Bradykinin acutely inhibits activity of the epithelial Na+ channel in mammalian aldosterone-sensitive distal nephron

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Three candidate genes and angiotensin-converting enzyme inhibitor-related cough: a pharmacogenetic analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Contributions of renin-angiotensin system-related gene interactions to obesity in a Chinese population

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Associations between hypertension and genes in the renin-angiotensin system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

Polymorphic genes for kinin receptors, nephropathy and blood pressure in type 2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06683-7_6

10.1007/978-3-319-06683-7_6

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25130042%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference